Influencing factors and path analysis of posttraumatic growth in patients with autoimmune diseases
-
By
-
Zheyuan Xia
-
Leran Tang
-
Ting Yao
-
Qiao Hu
-
Xiao Wang
-
Xiang Wang
-
June 10, 2026
-
Clinical Scorecard: Determinants and Pathway Analysis of Posttraumatic Growth in Individuals with Autoimmune Disorders
At a Glance
| Category | Detail |
|---|
| Condition | Autoimmune Diseases |
| Key Mechanisms | Fear of disease progression, social support, illness perception, coping modes |
| Target Population | Patients with autoimmune diseases |
| Care Setting | Rheumatology and immunology departments of tertiary hospitals |
Key Highlights
- Study involved 317 patients with autoimmune diseases.
- Posttraumatic growth score was 52.20 ± 13.87.
- Fear of disease progression positively associated with posttraumatic growth.
- Three significant mediating pathways identified.
- Cross-sectional design indicates covarying relationships among variables.
Guideline-Based Recommendations
Diagnosis
- Assess psychological distress and coping strategies in patients.
Management
- Strengthen social support systems.
- Guide reduction of avoidance coping.
- Alleviate negative illness perception.
Monitoring & Follow-up
- Regularly evaluate patients' fear of disease progression.
Risks
- Excessive fear may lead to avoidance coping, inhibiting psychological growth.
Patient & Prescribing Data
Patients with autoimmune diseases experiencing psychological distress.
Facilitate posttraumatic growth through supportive interventions.
Clinical Best Practices
- Utilize the Transactional Model of Stress and Coping for patient assessments.
- Incorporate psychological support in treatment plans.
Related Resources & Content
